These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 773578)

  • 1. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.
    Thomson AW; Moon DK; Geczy CL; Nelson DS
    Immunology; 1983 Feb; 48(2):291-9. PubMed ID: 6337088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stimulation of phagocytic function by factors inhibiting leukocyte and macrophage migration in humans].
    Gankovskaia LV; Tskhovrebova AZ; Gvozdeva NA; Koval'chuk LV; Cheredeev AN
    Biull Eksp Biol Med; 1986 Aug; 102(8):210-3. PubMed ID: 3527300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactoferrin stimulates the production of leucocyte migration inhibitory factor by human peripheral mononuclear leucocytes.
    Kijlstra A; Broersma L
    Clin Exp Immunol; 1984 Feb; 55(2):459-64. PubMed ID: 6365377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of cyclic AMP on leucocyte inhibitory factor (LIF) production and on the inhibition of leucocyte migration.
    Lomnitzer R; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1976 Apr; 24(1):42-8. PubMed ID: 181189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of in vitro lymphokine synthesis by glucocorticosteroids.
    Wahl SM; Altman LC; Rosenstreich DL
    J Immunol; 1975 Aug; 115(2):476-81. PubMed ID: 1097517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants.
    Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S
    J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro.
    Nelson RD; Leu RW
    J Immunol; 1975 Feb; 114(2 Pt 1):606-9. PubMed ID: 47355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune interferon. II. Different cellular site for the production of murine macrophage migration inhibitory factor and interferon.
    Neumann C; Sorg C
    Eur J Immunol; 1978 Aug; 8(8):582-9. PubMed ID: 359337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokines. II. Use of horse monocytes as indicator cells for human MIF.
    Friedrich W; Lazary S; de Weck AL
    Int Arch Allergy Appl Immunol; 1976; 50(2):142-54. PubMed ID: 1107231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of PHA-activated MN-cell supernatants on polymorphonuclear leucocyte function.
    Lomnitzer R; Glover A; Rabson AR
    Clin Exp Immunol; 1977 Sep; 29(3):501-8. PubMed ID: 589867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokines. VI. Factors in human and other heterologous sera inhibiting the migration of guinea pig macrophages.
    Baer R; Vogt K; Lazary S; Geczy C; de Weck AL
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):130-43. PubMed ID: 746681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lymphokine resembling transfer factor that stimulates MIF production by nonsensitive lymphocytes.
    Philp JR; McCormack JG; Moore AL; Johnson JE
    J Immunol; 1981 Apr; 126(4):1469-72. PubMed ID: 7009741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charge-reducing lymphokine activity in Concanavalin A-stimulated lymphocyte supernatants: preliminary biological and biochemical characterization.
    Kotzsch M; Grossmann H; Irmscher J; Wagner H; Müller M
    Biomed Biochim Acta; 1984; 43(1):57-65. PubMed ID: 6372798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of migration inhibition tests in penicillin hypersensitivity.
    Warrington RJ; Sauder PJ; Rutherford WJ
    Clin Exp Immunol; 1979 Oct; 38(1):148-57. PubMed ID: 393437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of macrophage glycolipids as receptors for migration inhibitory factor (MIF).
    Higgins TJ; Sabatino AP; Remold HG; David JR
    J Immunol; 1978 Sep; 121(3):880-6. PubMed ID: 357658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.